The Pennsylvania Postmarket Multicenter Experience With Flow Redirection Endoluminal Device
Sign Up to like & getrecommendations! Published in 2022 at "Neurosurgery"
DOI: 10.1227/neu.0000000000001970
Abstract: BACKGROUND: The flow redirection endoluminal device (FRED) is a novel self-expanding double-layer nitinol braided flow diverter that recently received FDA approval. However, early postmarket studies from the United States are lacking. OBJECTIVE: To report our… read more here.
Keywords: postmarket; flow redirection; multicenter; device ... See more keywords